NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Perhaps my recollection is inaccurate but I seem to remember LP saying that they would be looking at molecular sub-groups as part of their "many chances to win". LL is very interested in molecular groups from her research and I am quite certain that she has made suggestions along these lines for the SAP. I also seem to recall that LL/RP concluded, again from their prior studies, that the vaccine, whatever they used, had little to no effect on pro-neural. No mention was made to G-Cimp +/- or other specific signatures. The conclusion was generic.

You may indeed be correct, but the molecular landscape is still confusing--at least to me. That is why I have addressed these issues in hopes of some clarification. Your point of view is certainly not a negative. JMHO.